Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Hypogonadism × Clear all

Phase

Phase 2 5 Phase 1 4 Phase 3 3 Phase NA 1 Phase 4 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 3802 Neoplasms 2951 Prostatic Neoplasms 1731 Colorectal Neoplasms 1412 Lung Neoplasms 1300 Motor Activity 789 Head and Neck Neoplasms 674 Pancreatic Neoplasms 654 Colonic Neoplasms 649 Uterine Cervical Neoplasms 635 Carcinoma, Non-Small-Cell Lung 620 Carcinoma, Hepatocellular 619 Rectal Neoplasms 565 Stomach Neoplasms 531 Brain Neoplasms 475 Ovarian Neoplasms 432 Pain 412 Anxiety Disorders 412 Neoplasm Metastasis 382 Esophageal Neoplasms 379 Polycystic Ovary Syndrome 370 Precursor Cell Lymphoblastic Leukemia-Lymphoma 352 Urinary Bladder Neoplasms 349 Fatigue 332 Melanoma 319 Multiple Myeloma 317 Lymphoma 305 Depression 300 Endometrial Neoplasms 285 Liver Neoplasms 277

Interventions

testosterone undecanoate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00119483 2011-09-05

Older Men and Testosterone

University Hospital of North Norway

Phase NA Completed

Hypogonadism, Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon ⚡